PDE4B and ovarian cancer: By demethylating m6A at the 3'UTR of phosphodiesterases PDE1C and PDE4B, FTO inhibits PDE1C and PDE4B expression and thereby enhances cAMP signaling, which suppresses ovarian cancer cells stemness [177].